← Back to Search

Procedure

Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

N/A
Waitlist Available
Research Sponsored by Sofwave Medical LTD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial involves using the Sofwave System, a device designed to treat facial acne scars. The treatment is aimed at patients who have visible acne scars on their faces. The device works by sending energy into the skin to help it heal and reduce the appearance of scars.

Eligible Conditions
  • Acne Scars

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of change of acne scars appearance, as assessed by independent masked evaluators at 3 months post last treatment session.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Acne ScarsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sofwave
2020
Completed Phase 3
~240

Find a Location

Who is running the clinical trial?

Sofwave Medical LTDLead Sponsor
9 Previous Clinical Trials
512 Total Patients Enrolled

Media Library

Sofwave (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05358860 — N/A
~16 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top